LUPIN
Back to Balance Sheet
|
LUPIN Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹8,961 Cr | ₹8,502 Cr | ₹9,265 Cr | ₹8,276 Cr | ₹8,436 Cr |
What is the latest Total Current Liabilities ratio of LUPIN ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹8,961 Cr |
| Mar2024 | ₹8,502 Cr |
| Mar2023 | ₹9,265 Cr |
| Mar2022 | ₹8,276 Cr |
| Mar2021 | ₹8,436 Cr |
How is Total Current Liabilities of LUPIN Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹8,961 Cr | 5.41 | |
| Mar2024 | ₹8,502 Cr | -8.24 | |
| Mar2023 | ₹9,265 Cr | 11.95 | |
| Mar2022 | ₹8,276 Cr | -1.89 | |
| Mar2021 | ₹8,436 Cr | - | |
Compare Total Current Liabilities of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹107,189.4 Cr | 0.6% | 6.7% | 16.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,855.0 Cr | 2.4% | 7.1% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,550.0 Cr | -0.2% | 3.8% | 15.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,906.0 Cr | 1.8% | 10.9% | 48.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,632.0 Cr | 1% | 4% | 16.6% | Stock Analytics | |
| CIPLA | ₹107,427.0 Cr | 0.3% | -0.9% | -6% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | 0.6% |
6.7% |
16.5% |
| SENSEX | -2.9% |
-8% |
5.3% |
You may also like the below Video Courses